Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Int J Oral Maxillofac Surg ; 36(6): 527-32, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17418531

RESUMEN

Chronic infections of bone such as osteomyelitis are frequent events, especially in immunocompromised or diabetic patients, and costly on a national level. Incorrect treatment or delayed diagnosis may lead to loss of the affected extremity or mandible. The aim of this study was to assess the possible value of urinary lysylpyridinoline (LP) and hydroxylysylpyridinoline (HP) concentrations in the monitoring of mandibular osteomyelitis. Patients were assigned to the following groups: group 1 (n=85), control; group 2a (n=38), patients with active disease; group 2b (n=25), patients of group 2a 6 months after successful treatment; group 2c (n=7), patients of group 2a with ongoing osteomyelitis 6 months after treatment. The range and upper limit of normal values (HP(max) and LP(max)) were determined in group 1. Levels of LP and HP were measured by high-performance liquid chromatography and fluorescence detection. There was a significant decrease (mean 45.43% for HP and 32.12% for LP) in samples of group 2b compared to 2a (P<0.001 for HP and LP). There was a significant increase in HP values in samples from group 2c compared to 2a (P=0.018). The urinary concentrations of HP and LP appear to act as a marker of disease activity, with a decrease reflecting treatment success and an increase or stable values indicating persistent disease. An inexpensive tool (US$5 per analysis) for the monitoring of osteomyelitis is described.


Asunto(s)
Aminoácidos/orina , Enfermedades Mandibulares/orina , Osteomielitis/orina , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/orina , Cromatografía/métodos , Métodos Epidemiológicos , Femenino , Fluorescencia , Humanos , Masculino , Enfermedades Mandibulares/diagnóstico , Enfermedades Mandibulares/cirugía , Persona de Mediana Edad , Osteomielitis/diagnóstico , Osteomielitis/cirugía , Recurrencia , Factores Sexuales
2.
Phytomedicine ; 13(7): 463-7, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16785038

RESUMEN

Malodorous necrotic ulcers in cancer patients are of major concern as it leads to social isolation and poor quality of life. Current medications and topical therapies have proven inadequate in their ability to reduce foul smell to acceptable levels. We report the positive experience we have had in using antibacterial essential oils in patients with incurable head and neck cancer and associated malodorous necrotic ulcers. All patients received a standard course of therapy with oral or systemic antibiosis. In addition, we rinsed the ulcers with an antibacterial essential oil mix (mainly based on Eucalyptus oil) twice a day. All patients experienced complete resolution of the foul smell by only the third or fourth day of therapy. As a secondary effect we saw that besides smell reduction the oils had anti-inflammatory effects on neoplastic ulcers. In some patients ulcers started to heal and achieved complete re-epithiliazation. The patients experienced great personal relief upon resolution of their malodorous conditions. Quality of life improved significantly with the resulting reintroduction of social contact with friends and relatives.


Asunto(s)
Carcinoma de Células Escamosas/complicaciones , Eucalyptus , Neoplasias de Cabeza y Cuello/complicaciones , Odorantes/prevención & control , Aceites de Plantas/uso terapéutico , Úlcera Cutánea/tratamiento farmacológico , Anciano , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/patología , Femenino , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/patología , Humanos , Masculino , Persona de Mediana Edad , Necrosis/tratamiento farmacológico , Calidad de Vida , Úlcera Cutánea/etiología , Úlcera Cutánea/patología
3.
J Cutan Pathol ; 33(2): 175-80, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16420315

RESUMEN

The sebaceous nevus syndrome describes the rare association of a sebaceous nevus with systemic features such as mental retardation, seizures and colobomas (among others). It is thought to be a cutaneous mosaic inherited as a paradominant trait. Three cases are provided illustrating the intraoral manifestations of the syndrome. The first histological comparison of contiguous mucosal and cutaneous lesions is provided. We also describe the possible association of SFM syndrome with a benign fibrous histiocytic lesion of the mandible. This and other mandibular tumors associated with the sebaceous nevus syndrome may have significant implications for patients. Awareness of the potential presence or development of significant intraoral lesions in association with the sebaceous nevus syndrome is important for those involved in the care of patients with this syndrome.


Asunto(s)
Mucosa Bucal/patología , Nevo/complicaciones , Anomalías Múltiples/patología , Niño , Femenino , Humanos , Masculino , Neoplasias de la Boca/etiología , Neoplasias de la Boca/patología , Nevo/patología , Papiloma/etiología , Papiloma/patología
4.
Lancet ; 364(9436): 766-70, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15337402

RESUMEN

BACKGROUND: A major goal of research in bone transplantation is the ability to avoid creation of secondary bone defects. We aimed to repair an extended mandibular discontinuity defect by growth of a custom bone transplant inside the latissimus dorsi muscle of an adult male patient. METHODS: Three-dimensional computed tomography (CT) scanning and computer-aided design techniques were used to produce an ideal virtual replacement for the mandibular defect. These data were used to create a titanium mesh cage that was filled with bone mineral blocks and infiltrated with 7 mg recombinant human bone morphogenetic protein 7 and 20 mL of the patient's bone marrow. Thus prepared, the transplant was implanted into the latissimus dorsi muscle and 7 weeks later transplanted as a free bone-muscle flap to repair the mandibular defect. FINDINGS: In-vivo skeletal scintigraphy showed bone remodelling and mineralisation inside the mandibular transplant both before and after transplantation. CT provided radiological evidence of new bone formation. Postoperatively, the patient had an improved degree of mastication and was satisfied with the aesthetic outcome of the procedure. INTERPRETATION: Heterotopic bone induction to form a mandibular replacement inside the latissimus dorsi muscle in a human being is possible. This technique allows for a lower operative burden compared with conventional techniques by avoiding creation of a secondary bone defect. It also provides a good three-dimensional outcome.


Asunto(s)
Mandíbula/cirugía , Procedimientos de Cirugía Plástica/métodos , Ingeniería de Tejidos/métodos , Receptores de Activinas Tipo I , Células de la Médula Ósea/citología , Células de la Médula Ósea/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Humanos , Imagenología Tridimensional , Masculino , Mandíbula/diagnóstico por imagen , Neoplasias Mandibulares/cirugía , Persona de Mediana Edad , Osteogénesis , Complicaciones Posoperatorias , Proteínas/farmacología , Radiografía , Cintigrafía , Colgajos Quirúrgicos
5.
Br J Cancer ; 89(9): 1722-8, 2003 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-14583776

RESUMEN

The presence of an oral squamous cell carcinoma (OSCC) may be associated with increased urinary excretion of the markers of collagen degradation, hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). We investigated the possibility of these markers predicting the presence of active disease. Patients from a current study on HP and LP were included as follows: Group 1a (OSCC with confirmed mandibular bony infiltration, n=12), group 1b (group 1a patients >6 months after successful treatment), group 2a (OSCC without evidence of mandibular bone infiltration, n=8), group 2b (group 2a patients >6 months after successful treatment), group 3a (recurrent OSCC, n=8), group 3b (group 3a patients >6 weeks later, symptoms unchanged) and group 4 (control group, n=74). Tissue samples from tumour tissue and adjacent healthy mucosa were additionally investigated for HP and LP concentrations (n=8). The decrease in the urinary concentrations of HP and LP was statistically significant between groups 1a and 1b (P<0.001 for HP and LP), but not between groups 2a and 2b (P=0.07 for HP and LP), while values in groups 1b and 2b were within the normal range. When comparing groups 3a and 3b, a significant increase was observed for LP (P=0.050), but not HP (P=0.208). In conclusion, successful treatment of OSCC with bony involvement may be associated with a reduction of urinary HP and LP, whereas ongoing disease may result in an increase of LP. HP and LP may both be useful markers of tumour progression in patients with OSCC.


Asunto(s)
Aminoácidos/análisis , Biomarcadores de Tumor/análisis , Carcinoma de Células Escamosas/metabolismo , Neoplasias de la Boca/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/secundario , Carcinoma de Células Escamosas/orina , Colágeno/metabolismo , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Neoplasias Mandibulares/secundario , Persona de Mediana Edad , Neoplasias de la Boca/orina
6.
Br J Cancer ; 88(7): 1105-10, 2003 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-12671712

RESUMEN

Lysylpyridinoline (LP) and hydroxylysylpyridinoline (HP) are collagen crosslink residues of which the urinary concentration reflects the level of connective-tissue turnover. HP is ubiquitous in tissue, whereas LP is specific for bone. The purpose of this investigation was to assess the sensitivity and specificity of an increased urinary concentration of both HP and LP in indicating infiltration of mandibular bone by an oral squamous cell carcinoma (OSCC) or recurrence of the disease after successful therapy. We investigated the history and urine levels in 116 adult patients, who were divided into the following groups. Group 1: patients with OSCC with bone infiltration (n=17); group 2: patients with confirmed OSCC (n=12) without evidence of bone infiltration; group 3: patients with recurrence of an OSCC (n=13); group 4: patients without clinical evidence of disease (n=74). The range and upper limit of normal values (HP(max) and LP(max)) were measured from the normal controls in group 4. Levels of LP and HP were measured by HPLC and fluorescence detection. There was a significant difference in the average urinary levels of LP and HP between groups 1-4 (P<0.001). The presence of mandibular bone infiltration could be detected with a sensitivity and specificity of 100% when comparing groups 1 and 2. Presence of tumour tissue could be detected with a sensitivity of 90%. In conclusion, a normal LP concentration in patients with an OSCC strongly suggests that bone invasion by the disease has not taken place. If both urinary HP and LP are elevated, disease recurrence is highly likely.


Asunto(s)
Aminoácidos/orina , Carcinoma de Células Escamosas/orina , Colágeno/metabolismo , Neoplasias de la Boca/orina , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/patología , Humanos , Persona de Mediana Edad , Neoplasias de la Boca/patología , Estadificación de Neoplasias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA